|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.12.25 - 20:06
|
Relay Therapeutics Reports ′Robust Activity′ For Precision Breast Cancer Drug (Benzinga)
|
|
|
Relay Therapeutics shared interim data for zovegalisib at SABCS 2025, showing consistent efficacy in breast cancer patients.
Latest Ratings for RLAY
DateFirmActionFromTo Feb 2022BerenbergInitiates Coverage OnBuy Aug 2021HC Wainwright & Co.MaintainsBuy Jul 2021B of A SecuritiesInitiates Coverage OnBuy
View More Analyst Ratings for RLAY
View the Latest Analyst Ratings
read more...
|
|
|
|
|
|